Jove
Visualize
Contact Us

Related Experiment Videos

Ocular gene therapy: quo vadis?

W W Hauswirth1, L Beaufrere

  • 1Department of Molecular Genetics and Microbiology, Center for Gene Therapy, University of Florida, Gainesville 32610-0284, USA. hauswrth@eye1.eye.ufl.edu

Investigative Ophthalmology & Visual Science
|September 1, 2000
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miRNA-mediated post-transcriptional silencing of transgenes leads to increased adeno-associated viral vector yield and targeting specificity.

Gene therapy·2017
Same author

Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs.

Gene therapy·2016
Same author

Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs.

Gene therapy·2016
Same author

Healthy and diseased corticospinal motor neurons are selectively transduced upon direct AAV2-2 injection into the motor cortex.

Gene therapy·2015
Same author

Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs.

Gene therapy·2015
Same author

AAV8(Y733F)-mediated gene therapy in a Spata7 knockout mouse model of Leber congenital amaurosis and retinitis pigmentosa.

Gene therapy·2015
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies